THERAPEUTIC GENE BIOTECHNOLOGY
INDUSTRIAL CONSORTIUM ADVISORY BOARD

Under an academic paradigm set forth by the National Science Foundation for National Engineering Research Centers, BPEC exists as a partnership with industry. Regular two-way information flow ensures that the research is relevant to industry's needs, that our graduates receive state-of-the-art training, and that industry is made aware of breakthrough results as quickly as possible. Technology transfer is facilitated not only through frequent communication, but also through visiting scientist sabbaticals at MIT and student internships at our industrial partners.

We have selected an elite group of scientific leaders from industry to serve as Member Representatives on our Industrial Consortium Advisory Board (ICAB) in Therapeutic Gene Biotechnology. ICAB Member Representatives  review our research progress, point out our strengths, weaknesses, opportunities, and threats, and help set research strategy and focus areas. Member organizations that join ICAB may have up to three Representatives participate on the Board.

continue